carbenoxolone sodium has been researched along with Insulin Sensitivity in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Hady, EA; Bahaa, I; Saleh, N; Seif, AA | 1 |
| Chen, Y; Qian, Q; Yu, J | 1 |
| Campello, RS; Machado, UF; Mori, RC; Poças da Silva, T | 1 |
| Andrikopoulos, P; Caton, PW; Chapagain, A; Corder, R; Harwood, SM; Kieswich, J; Long, JH; Nayuni, N; Raftery, MJ; Seckl, JR; Thiemermann, C; Walker, BR; Webster, SP; Yaqoob, MM | 1 |
| Iwamura, T; Kainoh, M; Kawai, K; Kumagai, H; Nakaki, J; Nitta, A; Okazaki, S; Sakami, S; Sato, M; Sekiya, Y; Takahashi, T; Yagi, M | 1 |
| Du, H; Friedman, TC; Liu, L; Liu, Y; Lutfy, K; Nakagawa, Y; Ren, X; Wang, W; Wang, Y | 1 |
| Fotsch, C; Wang, M | 1 |
| Dhanesha, N; Dhote, V; Jain, M; Joharapurkar, A; Kshirsagar, S; Shah, G; Sharma, A | 1 |
| Andrews, RC; Rooyackers, O; Walker, BR | 1 |
| Abdallah, BM; Beck-Nielsen, H; Gaster, M | 1 |
| Flatt, PR; Gault, VA; Irwin, N; McKillop, AM; Taylor, A | 1 |
1 trial(s) available for carbenoxolone sodium and Insulin Sensitivity
| Article | Year |
|---|---|
Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Blood Glucose; Blood Pressure; Carbenoxolone; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Electrolytes; Enzyme Inhibitors; Humans; Hydroxysteroid Dehydrogenases; Insulin Resistance; Kinetics; Lipids; Male; Middle Aged | 2003 |
10 other study(ies) available for carbenoxolone sodium and Insulin Sensitivity
| Article | Year |
|---|---|
Comparative effect of vitamin D3 and carbenoxolone treatments in metabolic syndrome rats.
Topics: Animals; Blood Glucose; Carbenoxolone; Cholecalciferol; Insulin Resistance; Metabolic Syndrome; Rats; Rats, Wistar | 2022 |
Carbenoxolone ameliorates insulin sensitivity in obese mice induced by high fat diet via regulating the IκB-α/NF-κB pathway and NLRP3 inflammasome.
Topics: Animals; Carbenoxolone; Diet, High-Fat; Gene Expression Regulation; Inflammation; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; NF-kappa B; NF-KappaB Inhibitor alpha; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Random Allocation | 2019 |
Carbenoxolone enhances peripheral insulin sensitivity and GLUT4 expression in skeletal muscle of obese rats: Potential participation of UBC9 protein.
Topics: Animals; Anti-Ulcer Agents; Carbenoxolone; Gene Expression Regulation; Glucose Transporter Type 4; Hyperinsulinism; Insulin Resistance; Male; Muscle, Skeletal; Obesity; Rats; Rats, Wistar; Ubiquitin-Conjugating Enzymes | 2019 |
Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Analysis of Variance; Animals; Blood Glucose; Carbenoxolone; Corticosterone; Cytokines; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Immunoblotting; Insulin; Insulin Resistance; Liver; Mice; Mice, Knockout; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Renal Insufficiency, Chronic; RNA, Messenger; Uremia | 2014 |
HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adamantane; Administration, Oral; Animals; Azepines; Carbenoxolone; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Obesity; Pioglitazone; Thiazolidinediones; Triazoles | 2014 |
Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Blood Glucose; Body Weight; Carbenoxolone; Carbohydrate Dehydrogenases; Cells, Cultured; Corticosterone; Deoxyglucose; Dietary Fats; Gene Expression; Glucose Tolerance Test; Hepatocytes; Homeostasis; Immunoblotting; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Receptors, Glucocorticoid; RNA, Messenger | 2008 |
Blockade of glucocorticoid excess at the tissue level: inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 as a therapy for type 2 diabetes.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Carbenoxolone; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucocorticoids; Glycyrrhetinic Acid; Humans; Insulin Resistance; Obesity | 2008 |
Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adiposity; Animals; Anti-Obesity Agents; Brain; Carbenoxolone; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Energy Metabolism; Enzyme Inhibitors; Female; Glucose-6-Phosphatase; Hypoglycemic Agents; Insulin Resistance; Intra-Abdominal Fat; Liver; Metabolic Syndrome; Mice; Mice, Mutant Strains; Obesity; Pancreas; Phosphoenolpyruvate Carboxykinase (ATP) | 2012 |
Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Carbenoxolone; Cortisone; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Humans; Hydrocortisone; Insulin Resistance; Liver X Receptors; Middle Aged; Muscle Fibers, Skeletal; Obesity; Orphan Nuclear Receptors; Receptors, Cytoplasmic and Nuclear; Receptors, Glucocorticoid | 2005 |
Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Blood Glucose; Body Weight; Carbenoxolone; Corticosterone; Dietary Fats; Eating; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Mice; Obesity; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction | 2008 |